Track Rubicon Research Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -5.58 %
Low
1,390.0
High
1,514.8
1 Month returns: -14.95 %
Low
1,390.0
High
1,696.2
1 Year returns: 137.23 %
Low
570.8
High
1,899.0
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Rubicon Research Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Rubicon Research Ltd. Shareholding Pattern
Quarterly breakdown of Rubicon Research Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Rubicon Research Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Rubicon Research Ltd.?
The current share price of Rubicon Research Ltd. is ₹ 1,424.40 as of 23 Oct 2026.
What is the market capitalisation of Rubicon Research Ltd.?
The market capitalisation of Rubicon Research Ltd. stands at ₹ 23,578.40 Cr.
What is the PE ratio of Rubicon Research Ltd.?
The Price-to-Earnings (PE) ratio of Rubicon Research Ltd. is 81.81 as of the latest trailing twelve months data.
What is the ROE and ROCE of Rubicon Research Ltd.?
Rubicon Research Ltd. has a Return on Equity (ROE) of 26.97% and a Return on Capital Employed (ROCE) of 27.75% as per the latest financial reports.
What is the 52-week high and low of Rubicon Research Ltd.?
The 52-week high of Rubicon Research Ltd. is - and the 52-week low is -.
What is the dividend yield of Rubicon Research Ltd.?
The dividend yield of Rubicon Research Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Rubicon Research Ltd.?
Foreign Institutional Investors (FII) hold 7.52%, Domestic Institutional Investors (DII) hold 7.41% and retail/public investors hold 23.13% of Rubicon Research Ltd. shares.
What sector does Rubicon Research Ltd. belong to?
Rubicon Research Ltd. operates in the Healthcare sector.
What is the beta of Rubicon Research Ltd.?
The beta of Rubicon Research Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Rubicon Research Ltd.?
The 14-day Relative Strength Index (RSI) of Rubicon Research Ltd. is 27.34, placing it in the oversold zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Rubicon Research Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Analysts have been raising forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has increased by 3.9% in the last 3 months, indicating earnings momentum
What is Earnings upgrade (3M)?
Not enough data
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Expensive and at a premium to industry median P/E
PE TTM of 81.81 indicates that the stock is expensive on a standalone basis and is at a 168.49% premium to industry median P/E
What is P/E Ratio?
Median: 30.47
Value 81.81
-0.82614.73
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Company's earnings are of moderate quality
Earnings quality score of 46.8 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
46.8 / 100
Stock in ASM list
The stock has been places in Additional Surveillance Measure (ASM) list (LTASM - I (13)).
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Holdings and Presence
Indices and prominent investors with a stake in this stock.
History of Rubicon Research Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.
Dividend₹ 1.50/share
Record date: 7th Aug 2026Ex-date: 7th Aug 2026
Announced on: 29th May 2026
Company Profile
Overview of Rubicon Research Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Rubicon Research Ltd is an India-based pharmaceutical formulations company, which is focused on research and development, with a portfolio of specialty products and drug-device combination products targeting regulated markets, and particularly the United States. Its portfolio spans multiple dosage forms, including oral solids, oral liquids, nasal, and topical. Its technologies include RubiReten and RubiSRL. Its services include intellectual property evaluation and product design, formulation research development, analytical research development, technology transfer, dossier compilation and regulatory support, and clinical trials supplies. Its products are spread across many therapeutic areas, such as Analgesics/Pain Management, CVS, CNS, Hypokalemia, Skeletal Muscle Relaxants, NRT, Gastrointestinal, Metabolic, Immunosuppressant, and others. Others include Antipyretic, Hormonal Products, Diuretic, Antimuscarinics, Oral Rehydration Therapy, Over the Counter products, and Respiratory.
Rubicon Research Ltd is an India-based pharmaceutical formulations company, which is focused on research and development, with a portfolio of specialty products and drug-device combination products targeting regulated markets, and particularly the United States. Its portfolio spans multiple dosage f...